Funded Health Care Startups in Mumbai
Among the 28 Mumbai-area health care rounds shown (2020-03-16 through 2025-10-31), the largest disclosed amount is $40M for Toothsi on 2022-05-01.
Among the 28 Mumbai-area health care rounds shown (2020-03-16 through 2025-10-31), the largest disclosed amount is $40M for Toothsi on 2022-05-01. That figure stands out against the rest of the disclosed rounds, where most entries cluster between $1M and $22M, with only a handful above $16M (for example, Rubicon Research at $29M on 2025-08-14 and Pregna International at $16M on 2023-06-21).
The list also clusters by time: 10 rounds fall in the 2023 calendar year, and 6 more occur in 2024. Stage and disclosure are mixed—five entries are labeled “Series Unknown” (including Rubicon Research on 2025-08-14), and two are “undisclosed” (Mitsu on 2023-09-12; Swasthya AI on 2023-07-04).
Most recent rounds
28 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Mumbai health care set, and is it an outlier vs the rest of the disclosed amounts?
Toothsi’s $40M round on 2022-05-01 is the largest disclosed amount in the table. It’s materially higher than the next-largest disclosed figures, including Rubicon Research at $29M (2025-08-14) and a set of $22M/$18M/$16M rounds such as Truemeds ($22M, 2022-04-25), V-Ensure Pharma Technologies ($18M, 2022-02-21), and multiple $16M entries (SRV Hospital on 2025-04-19; Pregna International on 2023-06-21).
How concentrated are rounds in recent months/years within this 2020–2025 window?
The most recent activity runs from 2025-10-31 (Primaa) back through 2020-03-16 (HelpNow). Within that window, 10 rounds occur across calendar year 2023 (e.g., Evolve on 2023-12-19 through Tech Care For All on 2023-09-18), and another 6 rounds occur in 2024 (starting with The Good Bug on 2024-10-15 and including multiple Series A/seed rounds).
Which disclosure labels dominate—how many rounds are “Series Unknown” or “undisclosed”?
“Series Unknown” appears in 5 rows (e.g., Rubicon Research $29M on 2025-08-14; GoApptiv $5M on 2023-12-14; V-Ensure Pharma Technologies is labeled “Venture - Series Unknown” on 2022-02-21). “Undisclosed” appears in 2 rows—Mitsu (undisclosed) on 2023-09-12 and Swasthya AI (undisclosed) on 2023-07-04.
Does stage mix skew toward a particular stage label in this subset?
Seed rounds are recurring but not exclusive: Assure Clinic ($2M, 2024-11-18), Neodocs ($2M, 2024-02-08), and multiple smaller seeds like The Cube Club ($1M, 2023-10-03) and Welcome Cure ($480K, 2023-10-19). Series A also shows up repeatedly (Alyve Health $5M on 2024-06-18; Traya Health $9M on 2024-04-02; Amaha $6M on 2024-01-09; InnerHour $5M on 2021-02-04), alongside a later high-stage outlier like Toothsi’s Series C ($40M, 2022-05-01) and MakeO’s Series D ($16M, 2024-01-09).
Are there notable low-amount or high-amount outliers besides the top round?
On the low end, Tech Care For All records $50K as a disclosed round on 2023-09-18, and Evolve is $300K on 2023-12-19 (both far below the bulk of $1M+ entries like The Cube Club at $1M on 2023-10-03). On the high end, several rounds sit in the teens-to-20s range—SRV Hospital ($16M, 2025-04-19), MakeO ($16M, 2024-01-09), and V-Ensure Pharma Technologies ($18M, 2022-02-21)—but they do not match Toothsi’s $40M peak.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.